|
FR2850282B1
(fr)
|
2003-01-27 |
2007-04-06 |
Jerome Asius |
Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation
|
|
CN1882338A
(zh)
|
2003-09-18 |
2006-12-20 |
马库赛特公司 |
经巩膜递送
|
|
US8591885B2
(en)
*
|
2004-04-30 |
2013-11-26 |
Allergan, Inc. |
Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
|
|
US8541028B2
(en)
|
2004-08-04 |
2013-09-24 |
Evonik Corporation |
Methods for manufacturing delivery devices and devices thereof
|
|
US9993558B2
(en)
|
2004-10-01 |
2018-06-12 |
Ramscor, Inc. |
Sustained release eye drop formulations
|
|
KR101506925B1
(ko)
*
|
2004-10-01 |
2015-03-30 |
램스코르 인코포레이티드 |
편리하게 이식가능한 서방형 약물 조성물
|
|
JP5089397B2
(ja)
|
2004-11-22 |
2012-12-05 |
サントル ナシオナル ドゥ ラ ルシェルシェ シアンティフィク |
変異ネトリン４、その断片及びこれらの薬剤としての使用
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
WO2006086750A1
(en)
*
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Liquid formulations for treatment of diseases or conditions
|
|
WO2007019427A2
(en)
*
|
2005-08-08 |
2007-02-15 |
Massachusetts Eye & Ear Infirmary |
Methods and compositions for preserving the viability of photoreceptor cells
|
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
|
ES2643140T3
(es)
*
|
2005-12-22 |
2017-11-21 |
Oakwood Laboratories L.L.C. |
Sistema de suministro de liberación lenta sublimable y procedimiento de realización del mismo
|
|
US7756524B1
(en)
|
2006-01-31 |
2010-07-13 |
Nextel Communications Inc. |
System and method for partially count-based allocation of vocoder resources
|
|
US8636753B2
(en)
*
|
2006-02-08 |
2014-01-28 |
Tyrx, Inc. |
Temporarily stiffened mesh prostheses
|
|
US8591531B2
(en)
|
2006-02-08 |
2013-11-26 |
Tyrx, Inc. |
Mesh pouches for implantable medical devices
|
|
CA2635797C
(en)
|
2006-02-09 |
2015-03-31 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
|
US20090140212A1
(en)
*
|
2006-02-24 |
2009-06-04 |
Friedman Joel M |
Electron Transfer Through Glassy Matrices
|
|
WO2007112052A2
(en)
|
2006-03-23 |
2007-10-04 |
Macusight, Inc. |
Formulations and methods for vascular permeability-related diseases or conditions
|
|
US20070265329A1
(en)
*
|
2006-05-12 |
2007-11-15 |
Devang Shah T |
Methods for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV)
|
|
PT1864668E
(pt)
*
|
2006-06-01 |
2013-02-26 |
Novagali Pharma Sa |
Utilização de pró-fármacos para administração ocular intravítrea
|
|
DK2049081T3
(da)
|
2006-08-09 |
2013-02-25 |
Intarcia Therapeutics Inc |
Osmotiske leveringssystemer og stempelarrangementer
|
|
KR20090042926A
(ko)
*
|
2006-08-23 |
2009-05-04 |
노파르티스 아게 |
안 질환에 있어서의 ｐｋｃ 억제제, 특히 인돌릴말레이미드유도체의 용도
|
|
WO2008033924A2
(en)
*
|
2006-09-12 |
2008-03-20 |
Board Of Regents Of The University Of Nebraska |
Methods and compositions for targeted delivery of therapeutic agents
|
|
US20080138350A1
(en)
*
|
2006-10-20 |
2008-06-12 |
Bennett Michael D |
Process for use of fluoroquinolones to reduce or modulate inflammation due to eye disease or ophthalmic surgery
|
|
WO2008054725A2
(en)
*
|
2006-10-31 |
2008-05-08 |
Surmodics Pharmaceuticals, Inc. |
Spheronized polymer particles
|
|
US9023114B2
(en)
|
2006-11-06 |
2015-05-05 |
Tyrx, Inc. |
Resorbable pouches for implantable medical devices
|
|
NZ577281A
(en)
|
2006-12-18 |
2011-12-22 |
Takeda Pharmaceutical |
Sustained-release composition and method for producing the same
|
|
MX380318B
(es)
*
|
2007-03-07 |
2025-03-12 |
Abraxis Bioscience Llc |
Nanoparticula que comprende rapamicina y albumina como agente anticancer.
|
|
US8642067B2
(en)
|
2007-04-02 |
2014-02-04 |
Allergen, Inc. |
Methods and compositions for intraocular administration to treat ocular conditions
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
AU2008260447B2
(en)
*
|
2007-06-01 |
2013-10-10 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
|
US20080317805A1
(en)
*
|
2007-06-19 |
2008-12-25 |
Mckay William F |
Locally administrated low doses of corticosteroids
|
|
DK2173344T3
(en)
*
|
2007-06-29 |
2016-07-25 |
Clarencew Pty Ltd |
TREATMENT OR PROPHYLAXIS OF NEUROLOGICAL OR NEURO PSYCHIATRIC DISORDERS USING ocular administration
|
|
KR100882817B1
(ko)
*
|
2007-07-20 |
2009-02-10 |
숙명여자대학교산학협력단 |
보툴리늄 독소를 유효성분으로 포함하는 지방세포 생착증진용 약학적 조성물
|
|
US8124601B2
(en)
*
|
2007-11-21 |
2012-02-28 |
Bristol-Myers Squibb Company |
Compounds for the treatment of Hepatitis C
|
|
US20110097408A1
(en)
*
|
2007-12-10 |
2011-04-28 |
O'malley Bert W |
Chitosan-based matrices and uses thereof
|
|
JP5502751B2
(ja)
|
2007-12-20 |
2014-05-28 |
エボニック コーポレイション |
低残留溶媒濃度を有する微粒子を調製するためのプロセス
|
|
US20110104253A1
(en)
|
2008-01-18 |
2011-05-05 |
Horst Kief |
Agent for intra-articular injection
|
|
CA2726861C
(en)
|
2008-02-13 |
2014-05-27 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
US20090226547A1
(en)
*
|
2008-03-05 |
2009-09-10 |
Gilbard Jeffrey P |
Dietary Supplement For Eye Health
|
|
US8883768B2
(en)
*
|
2008-04-18 |
2014-11-11 |
Warsaw Orthopedic, Inc. |
Fluocinolone implants to protect against undesirable bone and cartilage destruction
|
|
US9132119B2
(en)
*
|
2008-04-18 |
2015-09-15 |
Medtronic, Inc. |
Clonidine formulation in a polyorthoester carrier
|
|
US9125917B2
(en)
*
|
2008-04-18 |
2015-09-08 |
Warsaw Orthopedic, Inc. |
Fluocinolone formulations in a biodegradable polymer carrier
|
|
CA2730760A1
(en)
*
|
2008-07-16 |
2010-01-21 |
Surmodics Pharmaceuticals, Inc. |
Process for preparing microparticles containing bioactive peptides
|
|
US8697155B2
(en)
*
|
2008-07-22 |
2014-04-15 |
Mayo Foundation For Medical Education And Research |
Treatment of obesity and related disorders
|
|
GB2479069B
(en)
*
|
2008-09-24 |
2012-07-25 |
Stabilitech Ltd |
Method for preserving polypeptides using a sugar and polyethyleneimine
|
|
US20110212127A1
(en)
*
|
2008-09-24 |
2011-09-01 |
Stabilitech Ltd. |
Method for Preserving Polypeptides Using a Sugar and Polyethyleneimine
|
|
WO2010042163A2
(en)
*
|
2008-10-06 |
2010-04-15 |
The Johns Hopkins University |
Quinoline compounds as inhibitors of angiogenesis, human methionine aminopeptidase, and sirt1, and methods of treating disorders
|
|
EP2344155B1
(en)
|
2008-10-09 |
2017-09-06 |
Ramscor, Inc. |
Composition and method for treating dry eye syndrome
|
|
AT507187B1
(de)
|
2008-10-23 |
2010-03-15 |
Helmut Dr Buchberger |
Inhalator
|
|
CA3045436C
(en)
*
|
2009-01-29 |
2025-10-07 |
Forsight Vision4, Inc. |
ADMINISTRATION OF A MEDICATION IN THE POSTERIOR SEGMENT
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
WO2011031476A2
(en)
*
|
2009-08-25 |
2011-03-17 |
Emory University |
Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation
|
|
NZ598686A
(en)
|
2009-09-28 |
2014-05-30 |
Intarcia Therapeutics Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
|
US20110097380A1
(en)
*
|
2009-10-28 |
2011-04-28 |
Warsaw Orthopedic, Inc. |
Clonidine formulations having antimicrobial properties
|
|
ES2617921T3
(es)
|
2010-03-31 |
2017-06-20 |
Stabilitech Ltd. |
Excipientes para estabilizar partículas virales
|
|
KR101819250B1
(ko)
|
2010-03-31 |
2018-01-16 |
스타빌리테크 리미티드 |
알룸 아쥬반트 및 알룸 아쥬반트를 포함하는 백신의 보존방법
|
|
CN102892424B
(zh)
|
2010-03-31 |
2015-04-01 |
稳定性科技有限公司 |
病毒颗粒的稳定
|
|
DE102010013898A1
(de)
*
|
2010-04-01 |
2011-10-06 |
Acino Ag |
Implantatskanüle mit Implantat und Verfahren zum Befestigen von Implantaten in einer Injektionskanüle
|
|
WO2012019136A2
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision 4, Inc. |
Injector apparatus and method for drug delivery
|
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
US9492315B2
(en)
|
2010-08-05 |
2016-11-15 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
CN101972236A
(zh)
*
|
2010-10-13 |
2011-02-16 |
北京诚创康韵医药科技有限公司 |
一种含吡非尼酮的缓释制剂
|
|
AU2011329656B2
(en)
|
2010-11-19 |
2017-01-05 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
WO2012097258A2
(en)
*
|
2011-01-15 |
2012-07-19 |
The Regents Of The University Of California |
Formulations for the prevention and treatment of wolbachia-related disease
|
|
PL2672847T3
(pl)
|
2011-02-11 |
2015-10-30 |
Batmark Ltd |
Część składowa inhalatora
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
BR112013031685B1
(pt)
*
|
2011-06-10 |
2021-04-06 |
Icon Bioscience, Inc. |
Formulações de liberação prolongada para entrega de proteínas ao olho e métodos de preparar as mesmas
|
|
EP4249059B1
(en)
|
2011-06-28 |
2025-07-30 |
ForSight Vision4, Inc. |
An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
|
|
EP2739252A4
(en)
|
2011-08-05 |
2015-08-12 |
Forsight Vision4 Inc |
SMALL MOLECULE ADMINISTRATION USING AN IMPLANTABLE THERAPEUTIC DEVICE
|
|
EP3903733B1
(en)
|
2011-09-16 |
2025-08-27 |
ForSight Vision4, Inc. |
Fluid exchange apparatus
|
|
GB201117233D0
(en)
|
2011-10-05 |
2011-11-16 |
Stabilitech Ltd |
Stabilisation of polypeptides
|
|
US20130190839A1
(en)
*
|
2012-01-20 |
2013-07-25 |
Jane Rapsey |
Drug delivery using a sacrificial host
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
AU2013256130B2
(en)
|
2012-05-03 |
2017-12-21 |
Alcon Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
US10688041B2
(en)
|
2012-05-03 |
2020-06-23 |
Kala Pharmaceuticals, Inc. |
Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
|
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
UA116217C2
(uk)
|
2012-10-09 |
2018-02-26 |
Санофі |
Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону
|
|
US20140105956A1
(en)
*
|
2012-10-11 |
2014-04-17 |
Rupak BANERJEE |
Biodegradable polymer based microimplant for ocular drug delivery
|
|
EP2922919B1
(en)
|
2012-11-21 |
2020-03-25 |
University Of Louisville Research Foundation, Inc. |
Compositions and methods for reducing oxidative damage
|
|
CA2895875A1
(en)
|
2012-12-21 |
2014-06-26 |
Sanofi |
Exendin-4 derivatives
|
|
US9283231B2
(en)
|
2013-01-31 |
2016-03-15 |
Icon Bioscience, Inc. |
Sustained release formulations for the treatment of intraocular pressure of glaucoma
|
|
HK1217092A1
(zh)
|
2013-02-15 |
2016-12-23 |
Kala Pharmaceuticals, Inc. |
治疗性化合物及其用途
|
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
|
ES2831625T3
(es)
|
2013-02-20 |
2021-06-09 |
Kala Pharmaceuticals Inc |
Compuestos terapéuticos y sus usos
|
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US9526654B2
(en)
|
2013-03-28 |
2016-12-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
|
WO2014167326A1
(en)
*
|
2013-04-09 |
2014-10-16 |
Cresset Biomolecular Discovery Ltd |
The local treatment of inflammatory ophthalmic diseases
|
|
CN110339153A
(zh)
|
2013-05-24 |
2019-10-18 |
爱康生物科技有限公司 |
地塞米松单位剂型、试剂盒及白内障手术后炎症中的应用
|
|
CA2919892C
(en)
|
2013-08-12 |
2019-06-18 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded immediate release abuse deterrent pill
|
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
US9458169B2
(en)
|
2013-11-01 |
2016-10-04 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
EP3080154B1
(en)
|
2013-12-13 |
2018-02-07 |
Sanofi |
Dual glp-1/gip receptor agonists
|
|
WO2015086733A1
(en)
|
2013-12-13 |
2015-06-18 |
Sanofi |
Dual glp-1/glucagon receptor agonists
|
|
EP3080150B1
(en)
|
2013-12-13 |
2018-08-01 |
Sanofi |
Exendin-4 peptide analogues as dual glp-1/gip receptor agonists
|
|
WO2015086730A1
(en)
|
2013-12-13 |
2015-06-18 |
Sanofi |
Non-acylated exendin-4 peptide analogues
|
|
US9492444B2
(en)
|
2013-12-17 |
2016-11-15 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
WO2015095391A1
(en)
|
2013-12-17 |
2015-06-25 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
TW201625670A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
衍生自ｅｘｅｎｄｉｎ－４之雙重ｇｌｐ－１／升糖素受體促效劑
|
|
TW201625669A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
衍生自艾塞那肽－４（Ｅｘｅｎｄｉｎ－４）之肽類雙重ＧＬＰ－１／升糖素受體促效劑
|
|
TW201625668A
(zh)
|
2014-04-07 |
2016-07-16 |
賽諾菲公司 |
作為胜肽性雙重ｇｌｐ－１／昇糖素受體激動劑之艾塞那肽－４衍生物
|
|
GB201406569D0
(en)
|
2014-04-11 |
2014-05-28 |
Stabilitech Ltd |
Vaccine compositions
|
|
EA201692083A1
(ru)
|
2014-04-16 |
2017-03-31 |
Вейкс-Фарма Гмбх |
Фармацевтическая композиция для ветеринарии и ее применение
|
|
US9932381B2
(en)
|
2014-06-18 |
2018-04-03 |
Sanofi |
Exendin-4 derivatives as selective glucagon receptor agonists
|
|
MX384889B
(es)
|
2014-07-15 |
2025-03-14 |
Forsight Vision4 Inc |
Dispositivo y metodo de entrega de implante ocular.
|
|
DK3169315T3
(da)
|
2014-07-17 |
2020-08-10 |
Pharmaceutical Manufacturing Res Services In |
Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
|
|
WO2016019165A1
(en)
|
2014-07-30 |
2016-02-04 |
Massachusetts Eye And Ear Infirmary |
Methotrexate for proliferative vitreoretinopathy
|
|
RU2017105844A
(ru)
|
2014-08-08 |
2018-09-11 |
Форсайт Вижн4, Инк. |
Стабильные и растворимые составы ингибиторов рецепторных тирозинкиназ и способы их получения
|
|
US20160045439A1
(en)
*
|
2014-08-15 |
2016-02-18 |
PixarBio Corporation |
Compositions for inhibiting inflammation in a subject with a spinal cord injury and methods of using the same
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
JP2017531026A
(ja)
|
2014-10-20 |
2017-10-19 |
ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド |
徐放性乱用抑止性液体充填剤形
|
|
GB2535427A
(en)
|
2014-11-07 |
2016-08-24 |
Nicoventures Holdings Ltd |
Solution
|
|
AU2015346450B2
(en)
|
2014-11-10 |
2020-01-30 |
Forsight Vision4, Inc. |
Expandable drug delivery devices and method of use
|
|
WO2016130478A1
(en)
|
2015-02-09 |
2016-08-18 |
University Of Louisville Research Foundation, Inc. |
Ophthalmic compositions and methods for reducing oxidative damage to an eye lens
|
|
HK1246641A1
(zh)
*
|
2015-03-18 |
2018-09-14 |
参天制药株式会社 |
缓释性医药组合物
|
|
AU2016270984B2
(en)
|
2015-06-03 |
2021-02-25 |
Intarcia Therapeutics, Inc. |
Implant placement and removal systems
|
|
AR105319A1
(es)
|
2015-06-05 |
2017-09-27 |
Sanofi Sa |
Profármacos que comprenden un conjugado agonista dual de glp-1 / glucagón conector ácido hialurónico
|
|
AR105284A1
(es)
|
2015-07-10 |
2017-09-20 |
Sanofi Sa |
Derivados de exendina-4 como agonistas peptídicos duales específicos de los receptores de glp-1 / glucagón
|
|
GB2542838B
(en)
|
2015-10-01 |
2022-01-12 |
Nicoventures Trading Ltd |
Aerosol provision system
|
|
CN105496947A
(zh)
*
|
2015-11-19 |
2016-04-20 |
苏州桓晨医疗科技有限公司 |
一种药物缓释制剂
|
|
CN113069681B
(zh)
|
2015-11-20 |
2022-12-23 |
弗赛特影像4股份有限公司 |
制造用于缓释药物递送的治疗装置的方法
|
|
EP3439591B1
(en)
|
2016-04-05 |
2020-09-23 |
ForSight Vision4, Inc. |
Implantable ocular drug delivery devices
|
|
MA53353A
(fr)
|
2016-05-16 |
2021-06-09 |
Intarcia Therapeutics Inc |
Polypeptides sélectifs pour le récepteur du glucagon et méthodes pour leur utilisation
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
WO2017218284A1
(en)
*
|
2016-06-13 |
2017-12-21 |
Massachusetts Eye And Ear Infirmary |
Local orbital therapy for thyroid eye disease
|
|
CN109310680B
(zh)
|
2016-06-30 |
2022-11-01 |
度瑞公司 |
长效配制物
|
|
US10682340B2
(en)
|
2016-06-30 |
2020-06-16 |
Durect Corporation |
Depot formulations
|
|
AU2017324713B2
(en)
|
2016-09-08 |
2020-08-13 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
US10392399B2
(en)
|
2016-09-08 |
2019-08-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
US10336767B2
(en)
|
2016-09-08 |
2019-07-02 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
|
US10369190B2
(en)
|
2016-09-13 |
2019-08-06 |
Allergan, Inc. |
Non-protein clostridial toxin compositions
|
|
CN110225762A
(zh)
|
2017-01-03 |
2019-09-10 |
因塔西亚制药公司 |
包括glp-1受体激动剂的连续施用和药物的共同施用的方法
|
|
GB2562241B
(en)
|
2017-05-08 |
2022-04-06 |
Stabilitech Biopharma Ltd |
Vaccine compositions
|
|
JP7314155B2
(ja)
|
2017-11-21 |
2023-07-25 |
フォーサイト・ビジョン４・インコーポレーテッド |
膨張可能ポート送達システムのための流体交換装置及びその使用方法
|
|
US11654166B2
(en)
|
2018-01-02 |
2023-05-23 |
Armata Pharmaceuticals, Inc. |
Therapeutic bacteriophage compositions for treating Staphylococcus infection
|
|
WO2019156230A1
(ja)
|
2018-02-08 |
2019-08-15 |
テルモ株式会社 |
医療器具およびこれを用いた癒合促進デバイス
|
|
US11065003B2
(en)
|
2018-03-19 |
2021-07-20 |
Terumo Kabushiki Kaisha |
Treatment method for joining biological organs
|
|
JP2021523222A
(ja)
*
|
2018-05-01 |
2021-09-02 |
チビ，インコーポレイティド |
網膜への薬剤の持続送達のための点眼剤および方法
|
|
CN112367981B
(zh)
|
2018-05-01 |
2024-06-04 |
奇比有限公司 |
用于将药剂无创地持续递送至眼部的液体储库
|
|
CN112638287A
(zh)
|
2018-09-27 |
2021-04-09 |
泰尔茂株式会社 |
愈合促进器具以及医疗设备
|
|
EP3845149B1
(en)
|
2018-09-27 |
2025-06-11 |
TERUMO Kabushiki Kaisha |
Adhesion promotion device
|
|
JP7386232B2
(ja)
|
2019-03-28 |
2023-11-24 |
テルモ株式会社 |
医療デバイス
|
|
CN113490458A
(zh)
|
2019-03-28 |
2021-10-08 |
泰尔茂株式会社 |
愈合促进设备
|
|
JP7390361B2
(ja)
|
2019-03-28 |
2023-12-01 |
テルモ株式会社 |
癒合促進デバイス
|
|
CN113646016B
(zh)
|
2019-03-28 |
2023-07-11 |
泰尔茂株式会社 |
医疗器械
|
|
KR20220062617A
(ko)
|
2019-09-13 |
2022-05-17 |
알데이라 테라퓨틱스, 아이엔씨. |
메토트렉세이트의 안과용 제형
|
|
US11911499B2
(en)
|
2019-11-07 |
2024-02-27 |
Resurge Therapeutics, Inc. |
System and method for prostate treatment
|
|
CN113262302B
(zh)
*
|
2020-02-17 |
2022-12-09 |
湖州惠中济世生物科技有限公司 |
可注射长效半固体凝胶制剂
|
|
AU2021282983A1
(en)
*
|
2020-06-01 |
2023-02-02 |
Ads Therapeutics Llc |
Topical ophthalmological compositions and methods for treating abnormal angiogenesis
|
|
JP2023532778A
(ja)
*
|
2020-07-07 |
2023-07-31 |
デルシテック オサケユイチア |
シリカハイドロゲルコンポジットおよびその使用
|
|
FI20215186A1
(en)
*
|
2021-02-19 |
2022-08-20 |
Rebio Tech Oy |
Compositions for ophthalmic treatment
|
|
US11197819B1
(en)
*
|
2021-04-09 |
2021-12-14 |
Drug Delivery Company, Llc |
Extended release bioabsorbable subcutaneous medicinal dosage delivery implant system
|
|
CN115463217B
(zh)
*
|
2021-06-11 |
2024-03-12 |
深圳埃格林医药有限公司 |
己酸羟孕酮在增强肿瘤治疗效果中的应用
|
|
EP4378493A4
(en)
|
2021-09-03 |
2024-11-27 |
TERUMO Kabushiki Kaisha |
MEDICAL ELEMENT
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
US11957654B2
(en)
|
2022-01-29 |
2024-04-16 |
Resurge Therapeutics, Inc. |
Treating benign prostatic hyperplasia
|
|
US11974979B2
(en)
|
2022-01-29 |
2024-05-07 |
Resurge Therapeutics, Inc. |
Treatments for benign prostatic hyperplasia
|
|
US11911385B1
(en)
|
2022-12-14 |
2024-02-27 |
Aldeyra Therapeutics, Inc. |
Methotrexate treatment methods
|
|
WO2025147589A1
(en)
|
2024-01-05 |
2025-07-10 |
Osanni Bio, Inc. |
Implants, compositions, and methods for treating retinal diseases and disorders
|
|
CN118388331B
(zh)
*
|
2024-05-07 |
2025-05-16 |
山东极地医药科技有限公司 |
一种羟基丙酮的生产工艺
|